Intended for healthcare professionals


Covid-19: Remdesivir probably reduces recovery time, but evidence is uncertain, panel finds

BMJ 2020; 370 doi: (Published 30 July 2020) Cite this as: BMJ 2020;370:m3049

Read our latest coverage of the coronavirus outbreak

  1. Elisabeth Mahase
  1. The BMJ

Remdesivir may be effective in reducing recovery time of patients with severe covid-19, although the certainty of the evidence is low, a panel of international experts has concluded.1

As part of The BMJ’s Rapid Recommendations initiative, the panel reviewed new evidence and made a weak recommendation for the use of the antiviral drug for patients with severe covid-19. They strongly supported continued enrolment of patients into ongoing clinical trials.

However, the panel also advised caution over the potential opportunity cost of using remdesivir …

View Full Text